Specialty drug spending growth characteristics in the U.S. 2012-2017
This statistic depicts the U.S. specialty drug market growth between 2012 and 2017. In that period, growth from specialty drugs which were for non-orphan indications amounted to an additional 82.1 billion U.S. dollars.